Innovating Preclinical Drug Discovery & Human Cell Therapy

Global Head of Research and Development for Cell Technologies
GE Healthcare Life Sciences, UK

Chief Scientist and Global Head of Research and Development
Research and Applied Markets
GE Healthcare Life Sciences Dr. Stephen Minger is Chief Scientist and Global Head of Research and Development, Research and Applied Markets, GE Healthcare Life Sciences. GE Healthcare Life Sciences is a $3.7 billion unit of GE Healthcare, and the Research and Applied Markets business provides world-class tools and technologies for drug discovery, cell science, cell bioprocessing, forensics and diagnostics. Stephen joined GE Healthcare Life Sciences in 2009 from King’s College, London where he was Senior Lecturer and Director of the Stem Cell Biology Laboratory.
As Director of the pioneering King’s College Stem Cell Biology Laboratory, Stephen was awarded one of the first UK licenses for the derivation of human embryonic stem cells. His group generated the first human embryonic stem cell line in the United Kingdom and went on to produce other stem cell lines including those containing mutations for Cystic Fibrosis and Huntington’s disease.
Stephen is co-founder and Director of the London Regenerative Medicine Network, the world’s largest multi-stakeholder cell therapy and regenerative medicine network, focused on helping to translate the potential benefits of cell therapy and regenerative medicine to the clinic.
Stephen received his PhD in Pathology (Neurosciences) in 1992 from the Albert Einstein College of Medicine, New York, followed by post-doctoral research at University of California, San Diego, where he first began to pursue research in neural stem cell biology. In 1995, Stephen was appointed Assistant Professor in Neurology at The University of Kentucky Medical School. He transferred his stem cell research programme to Guy's Hospital, London in 1996 and was appointed a Lecturer in Biomolecular Sciences at King's College London in 1998.
In 2012, Stephen was honored by Federation of Asian Biotech Associations (FABA) with a Special Award for his outstanding contributions in the field of stem cells.